Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2265640Generated: October 30, 2026

1-Methyl-4-(piperidin-4-yl)piperazine → Golvatinib

https://huagongshe.com/reaction/2265640

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Methyl-4-(piperidin-4-yl)piperazineHCID 795707—
Reactant[4-(3-fluoro-4-{[1-(4-fluorophenylcarbamoyl)cyclopropanecarbonyl]amino}phenoxy)pyridin-2-yl]-N-(phenoxycarbonyl)carbamic acid phenyl esterHCID 59597026—
SolventDimethylformamideHCID 6228—
ProductGolvatinibHCID 1611839272.8%

Reaction Steps

To a solution of phenyl N-[4-(3-fluoro-4-{[1-(4-fluorophenylcarbamoyl)cyclopropanecarbonyl]amino}phenoxy)pyridin-2-yl]-N-phenoxycarbonylcarbamate (50.0 mg) in N,N-dimethylformamide (2.0 ml) was added 1-methyl-4-(piperidin-4-yl)piperazine (68.7 mg), followed by stirring at room temperature for 12 hr. The reaction mixture was partitioned between ethyl acetate and a 1N aqueous solution of sodium hydroxide. The organic layer was washed with brine, and dried over anhydrous sodium sulfate. The solvent was removed, and the residue was purified by silica gel column chromatography (Fuji Silysia NH, ethyl acetate, ethyl acetate:methanol=20:1, then 10:1). Fractions containing the target compound were concentrated. To the residue was added diethyl ether:hexane=1:3, and the precipitate was collected by filtration. This was washed with hexane and dried under aeration to provide the titled compound as white powder (34.6 mg, 72.8%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07855290B2
Source datasetuspto-grants-2010_12
ORD IDord-411823316f93456185e0dca51c97a682
Source noteuspto-grants-2010_12